Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
AMGN Amgen
- 273.440
- -1.370-0.50%
Close Jan 22 16:00 ET
- 274.870
- +1.430+0.52%
Post 17:25 ET
146.98BMarket Cap34.92P/E (TTM)
275.015High272.069Low3.52MVolume272.660Open274.810Pre Close963.21MTurnover0.66%Turnover Ratio21.89P/E (Static)537.53MShares341.71352wk High19.53P/B146.61BFloat Cap253.30052wk Low8.88Dividend TTM536.16MShs Float341.713Historical High3.25%Div YieldTTM1.07%Amplitude7.887Historical Low273.848Avg Price1Lot Size
About Amgen Company
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Company Profile
SymbolAMGN
Company NameAmgen
Listing DateJun 1, 1983
Issue Price18.00
Founded1980
CEOMr. Robert A. Bradway
MarketNASDAQ
Employees26700
Fiscal Year Ends12-31
AddressOne Amgen Center Drive
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320-1799
Phone1-805-447-1000
Websitehttp://www.amgen.com
Company Executives
- Name
- Position
- Salary
- Robert A. Bradway
- Chairman of the Board, President and Chief Executive Officer
- 22.64M
- Nancy A. Grygiel
- Senior Vice President and Chief Compliance Officer
- --
- Peter H. Griffith
- Executive Vice President and Chief Financial Officer
- 6.02M
- Dr. James E. Bradner, M.D.
- Executive Vice President, Research and Development and Chief Scientific Officer
- --
- Matthew C. Busch
- Vice President, Finance and Chief Accounting Officer
- --
- Dr. David M. Reese, M.D.
- Executive Vice President and Chief Technology Officer
- 7.90M
- Rachna Khosla
- Senior Vice President, Business Development
- --
- Jonathan P. Graham
- Executive Vice President, General Counsel and Secretary
- --
- Murdo Gordon
- Executive Vice President, Global Commercial Operations
- 8.24M
- Derek Miller
- Senior Vice President, Human Resources
- --
- Esteban Santos
- Executive Vice President, Operations
- 7.21M
- Amy E. Miles
- Independent Director
- 359.92K
- Dr. S. Omar Ishrak
- Independent Director
- 366.47K
- Ellen J. Kullman
- Independent Director
- 360.29K
- Greg C. Garland
- Independent Director
- 379.92K
- Dr. Ronald D. Sugar
- Independent Director
- 379.92K
- Dr. Brian J. Druker, M.D.
- Independent Director
- 359.92K
- Michael V. Drake
- Independent Director
- 339.92K
- Charles M. Holley, Jr
- Independent Director
- 369.92K
- Dr. Robert Sanders Willia M.D.
- Independent Director
- 360.86K
- Professor Dr. Tyler E. Jacks, PhD
- Independent Director
- 339.92K
- Robert A. Eckert
- Lead Independent Director
- 419.92K
- Mary E. Klotman
- Independent Director
- --
- Dr. Wanda M. Austin
- Independent Director
- 359.92K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline?
Moomoo News Global
Dec 9, 2024 20:23
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011